Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jan 2;382(1):95.
doi: 10.1056/NEJMc1914047.

Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply

Thomas J Wang  1 , Daniel Muñoz  1 , William J Blot  1
Affiliations
Comment

Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply

Thomas J Wang et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Since the publication of their article, the authors report no further potential conflict of interest.

Comment on

References

    1. Indian Polycap S, Yusuf S, Pais P, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341–51. - PubMed
    1. Yusuf S, Lonn E, Pais P, et al. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. N Engl J Med 2016;374:2032–43. - PubMed
    1. Roshandel G, Khoshnia M, Poustchi H, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet 2019;394:672–83. - PubMed
    1. Munoz D, Uzoije P, Reynolds C, et al. Polypill for Cardiovascular Disease Prevention in an Underserved Population. N Engl J Med 2019;381:1114–23. - PMC - PubMed
    1. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596–e646. - PMC - PubMed

Substances